Who has invested in Amwell?

Anthem, Philips, Allianz, Teva Pharmaceuticals are named among the investors backing Amwell.

Amwell Funding: $500M Raised, IPO (2020)

Amwell funding overview

Amwell is based in Boston, MA. Amwell has raised $500M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in August 2020. The round record for Amwell runs through 2020; nothing later has been disclosed. Investors on record include Anthem, Philips, Allianz, Teva Pharmaceuticals. 4 distinct backers are named across the disclosed rounds.

Amwell at a glance

Total raised: $500M
Latest round: IPO
Latest round date: August 2020
Headquarters: Boston, MA
Notable investors: Anthem, Philips, Allianz, Teva Pharmaceuticals

Frequently asked about Amwell funding

How much has Amwell raised?: Amwell has raised $500M in total disclosed funding across the rounds on record.
Who has invested in Amwell?: Anthem, Philips, Allianz, Teva Pharmaceuticals are named among the investors backing Amwell.
What was the latest Amwell funding round?: The most recent disclosed round is an IPO, announced in August 2020.
Where is Amwell based?: Amwell is based in Boston, MA.
When did Amwell last raise?: The last disclosed Amwell round closed in August 2020 at IPO.

Totals shown for Amwell aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.

Amwell Funding: $500M Raised, IPO (2020)

Amwell funding overview

Amwell at a glance

Frequently asked about Amwell funding

Companies related to Amwell (22)

Browse related funding lists (6)